|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer 6/21/22 Allogene Therapeutics, Inc. SC TO-I 13:2.1M Allogene Therapeutics, Inc. |
Document/Exhibit Description Pages Size 1: SC TO-I Tender-Offer Statement by an Issuer HTML 58K 2: EX-FILING FEES Filing Fees HTML 15K 3: EX-99.(A)(1)(A) Miscellaneous Exhibit HTML 175K 4: EX-99.(A)(1)(B) Miscellaneous Exhibit HTML 12K 5: EX-99.(A)(1)(C) Miscellaneous Exhibit HTML 26K 6: EX-99.(A)(1)(D) Miscellaneous Exhibit HTML 13K 7: EX-99.(A)(1)(E) Miscellaneous Exhibit HTML 9K 8: EX-99.(A)(1)(F) Miscellaneous Exhibit HTML 9K 9: EX-99.(A)(1)(G) Miscellaneous Exhibit HTML 9K 10: EX-99.(A)(1)(H) Miscellaneous Exhibit HTML 8K 11: EX-99.(A)(1)(I) Miscellaneous Exhibit HTML 9K 12: EX-99.(A)(1)(J) Miscellaneous Exhibit HTML 9K 13: EX-99.(A)(1)(K) Miscellaneous Exhibit HTML 14K
| Document |
| Transaction Value | Fee Rate | Amount of Filing Fee | ||||||||||||||||||||||||
Fees to Be Paid | $ | 21,579,572.74 | (1) | 0.0000927 | $ | 2,000.43 | (2) | |||||||||||||||||||
Fees Previously Paid | ||||||||||||||||||||||||||
Total
Transaction Valuation | $ | 21,579,572.74 | (1) | |||||||||||||||||||||||
Total Fees Due for Filing | $ | 2,000.43 | ||||||||||||||||||||||||
Total Fees Previously Paid | ||||||||||||||||||||||||||
Total
Fee Offsets | ||||||||||||||||||||||||||
Net Fee Due | $ | 2,000.43 | ||||||||||||||||||||||||
| (1) | Estimated solely for purposes of calculating the amount of the filing fee. The calculation of the Transaction Valuation assumes that all stock options to purchase shares of the issuer’s common stock that may be eligible for exchange in the offer will be tendered pursuant to this offer. This calculation assumes stock options to purchase an aggregate of 4,011,073 shares of the issuer’s common stock, having an aggregate value of $21,579,572.74 as of June 16, 2022, calculated based on a Black-Scholes option pricing model, will be exchanged or cancelled pursuant to this offer. | ||||
| (2) | The amount of the filing fee, calculated in accordance with Rule 0-11(b) of the Securities Exchange Act of 1934, as amended, equals $92.70 per $1,000,000 of the aggregate amount of the Transaction Valuation (or 0.00927% of the aggregate Transaction Valuation). The Transaction Valuation set forth above was calculated for the sole purpose of determining the filing fee and should not be used for any other purpose. | ||||
| This ‘SC TO-I’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 6/21/22 | 4 | ||
| 6/16/22 | ||||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 6/17/22 Allogene Therapeutics, Inc. 8-K:5,9 6/15/22 11:205K 5/04/22 Allogene Therapeutics, Inc. 10-Q 3/31/22 59:5.9M 4/26/22 Allogene Therapeutics, Inc. DEF 14A 6/15/22 1:1.5M 2/23/22 Allogene Therapeutics, Inc. 10-K 12/31/21 83:12M 2/25/21 Allogene Therapeutics, Inc. 10-K 12/31/20 92:13M 5/06/20 Allogene Therapeutics, Inc. 10-Q 3/31/20 62:7.4M 2/27/20 Allogene Therapeutics, Inc. 10-K 12/31/19 96:15M 10/24/18 Allogene Therapeutics, Inc. S-8 10/24/18 5:523K Donnelley … Solutions/FA 10/05/18 Allogene Therapeutics, Inc. 8-A12B 1:14K Donnelley … Solutions/FA 10/02/18 Allogene Therapeutics, Inc. S-1/A 15:6.4M Donnelley … Solutions/FA 9/14/18 Allogene Therapeutics, Inc. S-1 14:7.5M Donnelley … Solutions/FA |